Prescription Drugs

July 14, 2022 | Controlled Substances, Law Enforcement, Legal & Legislative Research, Prescription Drugs, Public Safety

In this survey, the Legislative Analysis and Public Policy Association (LAPPA) examines the state-level legislative response to drugged driving. In Section I, it presents the existing laws on driving under the influence of drugs in the 50 states and the District of Columbia. Section II highlights a selection of additional resources for policymakers on drugged driving research and policy proposals in the United States. These resources include scientific studies, such as the latest research on the physiological effects of certain substances on drivers and the effectiveness of new testing methods and policy analysis, including recommendations from the U.S. Department of Justice on how to effectively detect and prosecute drugged driving. Together they illuminate the evolving landscape of drugged driving in the United States and the potential remedies that can keep Americans safe on the roads....

July 12, 2022 | Controlled Substances, Legal & Legislative Research, Opioids, Prescription Drugs, Substance Abuse, Synthetic Drugs

In this survey, the Legislative Analysis and Public Policy Association (LAPPA) examines the policy response at the state level to the spread of pill presses used to create counterfeit drugs. There is relatively little policy in this area compared to federal law, and most innovation is relatively recent.  Findings are presented jurisdiction by jurisdiction for easy comparison among states and between current state- and federal law....

June 22, 2022 | Controlled Substances, Opioids, Prescription Drugs, Public Health, Recovery, Reports & Studies, Substance Abuse, Treatments

The COVID-19 pandemic created an unprecedented public health emergency throughout the world, prompting providers to turn to telehealth to provide necessary health care to patients at a distance. This paper analyzes the current state of telehealth services at the federal and state levels, as well as the benefits and limitations of telehealth technology use. It also offers public policy recommendations to improve telehealth services in the United States....

May 19, 2022 | Controlled Substances, Harm Reduction, Innovative Initiatives, Law Enforcement, Opioids, Prescription Drugs, Public Health, Recovery, Substance Abuse, Treatments

The restaurant industry has been particularly impacted by the opioid epidemic with, for example, ten percent of food service workers dying from opioid overdoses in the State of Delaware.[1] This sobering statistic prompted the Delaware Division of Public Health (DPH) to launch the Restaurant Accolade Program (the Program), which trains all restaurant staff and owners in the state on how to identify, respond to, and reverse an opioid overdose and helps food establishments draft policies that support employees and patrons with substance use disorders (SUDs). The Office of Health Crisis Response (OCHR) within DPH conducts the training and education....

March 28, 2022 | Controlled Substances, Criminal Justice, Drug Courts, Law Enforcement, Opioids, Prescription Drugs, Public Health, Public Safety, Recovery, Reports & Studies, Substance Abuse, Synthetic Drugs

In September 2021, Georgetown University Law Center convened an Opioid Litigation Summit. This convening brought together numerous experts to discuss legal, administrative, and programmatic strategies needed to optimize the impact of proceeds from the opioid litigation. The themes described in this brief emerged from the Summit and can be applied to the opioid litigation as well as future mass tort litigation to address public health crises....

March 3, 2022 | Controlled Substances, Harm Reduction, Innovative Initiatives, Law Enforcement, Opioids, Prescription Drugs, Public Health, Recovery, Substance Abuse, Treatments

When Pennsylvania Attorney General Josh Shapiro learned that approximately 15 citizens of the Commonwealth of Pennsylvania die each day from an overdose, he took action. As a result, in May of 2018, he launched the Law Enforcement Treatment Initiative (LETI) to connect individuals suffering with a substance use disorder (SUD) to treatment resources....

February 8, 2022 | Controlled Substances, Criminal Justice, Harm Reduction, Medication Assisted Treatment (MAT), Naloxone, Opioids, Prescription Drugs, Public Health, Recovery, Substance Abuse, Toolkits, Treatments

The 2022 AMA-Manatt Toolkit builds on a previously published roadmap by providing actionable resources that states can use to take specific actions in six policy areas: (1) Increase access to evidence-based treatments to help patients with a substance use disorder (SUD); (2) Ensure access to addiction medicine, psychiatry, and other trained physicians; (3) Enforce mental health and substance use disorder (SUD) parity laws; (4) Improve access to multidisciplinary, multimodal care for patients with pain; (5) Expand harm reduction efforts to reduce death and disease; and (6) Improve monitoring and evaluation....

December 10, 2021 | Controlled Substances, Criminal Justice, Harm Reduction, Opioids, Prescription Drugs, Public Health, Recovery, Reports & Studies, Substance Abuse, Treatments

The Bloomberg School of Public Health at Johns Hopkins University recently released a three-part report about the multi-district opioid litigation that has been making its way through the court system for many years. Part 1 of the trilogy, focuses on a series of principles governing the use of the settlement funds: (1) spending money to save lives; (2) using evidence to guide spending; (3) investing in youth prevention; (4) focusing on racial equity; and (5) developing a fair and transparent process for deciding where to spend the funding....